Detalhe da pesquisa
1.
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
N Engl J Med;
386(12): 1132-1142, 2022 03 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35179323
2.
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.
Prostate;
84(9): 888-892, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38561317
3.
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
Cancer;
130(9): 1642-1649, 2024 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38180804
4.
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
Cancer;
2024 Apr 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38564301
5.
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).
Oncologist;
29(5): 450-e725, 2024 May 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38452035
6.
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
N Engl J Med;
385(22): 2036-2046, 2021 11 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34818478
7.
Oral HIF-2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.
Ophthalmology;
2024 Jun 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38849055
8.
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
BMC Cancer;
24(1): 493, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38637770
9.
Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.
Prostate;
83(16): 1602-1609, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37644774
10.
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
Oncologist;
28(8): 737-e693, 2023 08 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36952231
11.
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Cancer Immunol Immunother;
72(3): 775-782, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35998004
12.
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials.
Curr Treat Options Oncol;
24(9): 1199-1212, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37407886
13.
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021).
Lancet Oncol;
23(7): 899-909, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35690072
14.
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
Oncologist;
27(10): e815-e818, 2022 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36036607
15.
Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022.
Curr Oncol Rep;
24(9): 1201-1208, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35438388
16.
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.
Oncologist;
26(12): 1006-e2129, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34423501
17.
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
Oncologist;
26(9): 751-760, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34157173
18.
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
Oncologist;
26(2): e270-e278, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33215787
19.
Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma.
J Urol;
205(3): 709-717, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33080152
20.
What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.
Prostate;
80(5): 441-450, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32027768